"10.1371_journal.pmed.1001699","plos medicine","2014-08-12T00:00:00Z","Thomas Callender; Mark Woodward; Gregory Roth; Farshad Farzadfar; Jean-Christophe Lemarie; Stéphanie Gicquel; John Atherton; Shadi Rahimzadeh; Mehdi Ghaziani; Maaz Shaikh; Derrick Bennett; Anushka Patel; Carolyn S P Lam; Karen Sliwa; Antonio Barretto; Bambang Budi Siswanto; Alejandro Diaz; Daniel Herpin; Henry Krum; Thomas Eliasz; Anna Forbes; Alastair Kiszely; Rajit Khosla; Tatjana Petrinic; Devarsetty Praveen; Roohi Shrivastava; Du Xin; Stephen MacMahon; John McMurray; Kazem Rahimi","The George Institute for Global Health, University of Oxford, Oxford, United Kingdom; The George Institute for Global Health, University of Sydney, Sydney, Australia; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America; Non-Communicable Diseases Research Centre, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran; Effi-Stat, Paris, France; Department of Cardiology, Royal Brisbane and Women's Children Hospital and University of Queensland School of Medicine, Brisbane, Australia; Department of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; The George Institute for Global Health, Hyderabad, India; Clinical Trials Service Unit, University of Oxford, Oxford, United Kingdom; National University of Singapore, Singapore; Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; National Cardiovascular Centre University Indonesia, Jakarta, Indonesia; Universidad Nacional del Centro de la Provincia de Buenos Aires, Buenos Aires, Argentina; Centre Hospitalier Universitaire de Poitiers, Poitiers Cedex, France; Centre of Cardiovascular Research & Education in Therapeutics, Monash University, Melbourne, Australia; Bodleian Healthcare Libraries, University of Oxford, Oxford, United Kingdom; The George Institute for Global Health, Peking University, Beijing, China; University of Glasgow, Glasgow, United Kingdom","Analyzed the data: TC KR MW. Wrote the first draft of the manuscript: TC KR. Contributed to the writing of the manuscript: TC KR MW GR JM FF. ICMJE criteria for authorship read and met: TC MW GR FF JM KR JCL SG JA SR MG SM MS DB AP CSPL KS AB BBS AD DH HK TE AF AK RK TP DP RS DX. Agree with manuscript results and conclusions: TC MW GR FF JM KR JCL SG JA SR MG SM MS DB AP CSPL KS AB BBS AD DH HK TE AF AK RK TP DP RS DX. Designed the study: KR DB. Provided input on study design: DX AP SM. Designed the search strategy, and contributed to abstract reviews and data extraction plans: TE AF AK RK TP DP RS. Completed data extraction and coordinated the collection of unpublished data: KR TC. Provided input on writing of the manuscript and analyzing of the data: MW GR FF JM. Contributed significantly to reviewing the manuscript: JA HK KS DB AP CSPL. Contributed data: JCL SG SR MG FF MS JA BBS AB AD DH. TC had full access to all the data in the study and he takes responsibility for the integrity of the data and the accuracy of the data analysis.","CL is funded by a Clinician Scientist Award from the National Medical Research Council of Singapore; receives research grants from Boston scientific, Medtronic, and Vifor Pharma; and serves as a consultant for Bayer and Novartis. JML is employed by the contract research organization Effi-Stat, which receives funding from pharmaceutical and biotechnology companies. In 2009 and 2010 Effi-Stat received financial support from Sanofi-Aventis for providing statistical analysis and programming for the I-Prefer study included in this review (reference [70]). SG is employed by the contract research organization Effi-Stat, which receives research funding from pharmaceutical and biotechnology companies. AP is a member of the Editorial Board of PLOS Medicine.","2014","08","Thomas Callender","TC",30,TRUE,NA,NA,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
